Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.

about

Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R.

P2860

Q45071301-ABB7598A-6965-4BFF-8339-CED464867432

P2860

Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.

Item

http://www.wikidata.org/entity/Q40812131

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Favorable outcome of primary m ...... regimen without radiotherapy.

@en

type

Item

label

Favorable outcome of primary m ...... regimen without radiotherapy.

@en

prefLabel

Favorable outcome of primary m ...... regimen without radiotherapy.

@en

P1476

Favorable outcome of primary m ...... regimen without radiotherapy.

@en

P2093

Alex Gural

http://www.w3.org/2001/XMLSchema#string

David Lavie

http://www.w3.org/2001/XMLSchema#string

Diana Libster

http://www.w3.org/2001/XMLSchema#string

Dina Ben-Yehuda

http://www.w3.org/2001/XMLSchema#string

Geffen Kleinstern

http://www.w3.org/2001/XMLSchema#string

Marina Orevi

http://www.w3.org/2001/XMLSchema#string

Moshe E Gatt

http://www.w3.org/2001/XMLSchema#string

Neta Goldschmidt

http://www.w3.org/2001/XMLSchema#string

Ora Paltiel

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Primary mediastinal large B-cell lymphoma.

Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan.

Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.

The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.

Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

Primary mediastinal large B-cell lymphoma (PMLBCL): long-term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B.

P2888

s00280-016-3024-8

P304

1053-1060

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-016-3024-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1032555101

http://www.w3.org/2001/XMLSchema#string

P698

27056383

http://www.w3.org/2001/XMLSchema#string

Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.

about

P2860

P2860

Favorable outcome of primary mediastinal large B-cell lymphoma patients treated with sequential RCHOP-RICE regimen without radiotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698